Lin Patrick bought 1,582 shares of Processa Pharmaceuticals, Inc. at $2.57 for $4.07k on May 29, 2026

Buy
Form 4 code P. Open-market or private purchase of a non-derivative or derivative security.
Chief Business - Strategy Off
Chief Business - Strategy Off
Filed Jun 1, 2026

Facts from the filing

Form 4 · Non-derivative, table I
Disclosed value
$4,065.74Shares × reported price
Shares traded
1,582Common Stock
Price per share
$2.57Reported price. Read footnotes for ranges.
% of reported position traded
20.83%This security and ownership context
Holdings after
9,176Direct
Trade date
May 29, 2026Buy
Filed
Jun 1, 2026, 4:56 PM ET3-day reporting delay
Accession
0000897069-26-001289Code P · Transaction 388518
How reported position traded is calculated

Shares purchased ÷ (holdings after − shares purchased). Estimated position before: 7,594 shares.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

No other transaction rows in this filing.

1 transaction row in this filing. Joint filers share the same rows.

PCSA price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
PCSA · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago +4.7%1w ago +4.7%1d ago +4.3%
Returns since7d −4.3%30d −23%90d −19%180d1y

Footnotes in full

No footnotes recorded. Check the original SEC filing for the complete report.